Recently, a KLAK-MCP-1 micelle composed of CCR2-targeted peptide sequence and apoptosis-inducing KLAK peptide inhibited melanoma growth in B16F10 mouse models by inhibiting MCP-1/CCR2 axis and decreasing the recruitment of TAMs (147). Here, CCL2 is linked to melanoma.